Stem-cell funding passes House, faces veto threat

[Kirsten Nunez]

An interesting otc stock for your consideration.


Sym bol: FCCN
On: PinkSheets
5-Days Target: $2.70
Long Term Target: $9.00

Take a look at the annoucement and reveiw the technology, but grab some FCCN
before they drop the release to push this stock to the dollar marker.


DO YOUR DUE DILIGENCE ON THIS STOCK!!
RADAR IT FOR FRIDAY NOW!